U.S. market Open. Closes in 3 hours 48 minutes

ITRM | Iterum Therapeutics plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
RevenueN/AN/AN/AN/A37.00K869.00K508.00KN/A
Cost of Revenue1.75M1.80M2.10M161.00KN/AN/AN/AN/A
Gross Profit-1.75M-1.80M-2.10M-161.00K37.00K869.00K508.00KN/A
Operating Expenses47.47M30.38M24.54M32.13M102.06M77.43M29.96M13.36M
Selling, General & Admin7.48M12.77M13.82M11.05M11.28M8.78M4.46M3.26M
Research & Development38.24M17.62M10.71M21.07M90.77M68.65M25.50M10.10M
Other Operating ExpensesN/A-16.85M195.00K213.00K196.00K401.00K216.00K8.00K
Operating Income-47.47M-30.38M-24.54M-32.13M-102.02M-76.56M-29.45M-13.36M
Other Expenses / Income9.71M-13.75M-66.32M-19.14M-665.00K-25.00K493.00K8.00K
Before Tax Income-37.76M-44.13M-90.86M-51.26M-102.69M-76.58M-28.96M-13.35M
Income Tax Expenses613.00K301.00K705.00K743.00K444.00K472.00K444.00K113.00K
Net Income-38.37M-44.43M-91.56M-52.01M-103.13M-77.06M-29.41M-13.46M
Interest ExpensesN/A2.36M5.55M15.10M861.00K426.00KN/AN/A
Basic Shares Outstanding12.96M12.24M163.37M24.01M14.52M582.27K506.28K506.28K
Diluted Shares Outstanding12.96M12.24M163.37M24.01M14.52M582.27K506.28K506.28K
EBITDA-34.58M-39.97M-83.20M-36.01M-101.67M-76.02M-29.39M-13.35M
EBITDA Margin0.00%0.00%0.00%0.00%-274,791.89%-8,748.22%-5,785.43%0.00%
EBIT-37.76M-41.77M-85.31M-36.17M-101.83M-76.16M-28.96M-13.35M
EBIT Margin0.00%0.00%0.00%0.00%-275,202.70%-8,763.87%-5,701.18%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙